Regenerative Medical Technology (RMTG) Return on Sales (2018 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Return on Sales of 0.01% for Q1 2026, little changed year-over-year from 0.01% in Q1 2025, and up 49.53% quarter-over-quarter from 0.01% in Q4 2025.
Regenerative Medical Technology (RMTG) Return on Sales (2018 - 2026) Analysis & Trends
Regenerative Medical Technology's Return on Sales history runs 9 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
- The five-year high for Return on Sales was 0.08% in Q4 2023, with the low at 0.03% in Q3 2025.
- The 5-year median for Return on Sales is 0.01% (2026), against an average of 0.01%.
- The sharpest annual moves came in 2022 and 2024: Return on Sales jumped 106 bps in 2022, then declined 8 bps in 2024.
- Regenerative Medical Technology's Return on Sales stood at 0.0% in 2022, then surged by 6227 bps to 0.08% in 2023, then slumped by 106 bps to 0.0% in 2024, then tumbled by 248 bps to 0.01% in 2025, then surged by 50 bps to 0.01% in 2026.
- Business Quant data shows RMTG's Return on Sales at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | 0.08% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.05% |
| Sep 30, 2021 | -0.60% |
| Jun 30, 2021 | -0.44% |